Enzo Biochem Q4 EPS $(0.01), Sales $7.53M; Cash $52.4M
Portfolio Pulse from Benzinga Newsdesk
Enzo Biochem reported a Q4 loss of $(0.01) per share with sales of $7.53 million and cash reserves of $52.4 million.
October 30, 2024 | 8:19 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Enzo Biochem reported a Q4 loss of $(0.01) per share, with sales of $7.53 million. The company's cash reserves stand at $52.4 million.
The reported EPS of $(0.01) indicates a small loss, which might not significantly impact the stock price in the short term. Sales of $7.53 million and a strong cash position of $52.4 million provide a stable financial outlook, suggesting a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100